Personalized Medicine – Products
Product News
Thermo Fisher Scientific Introduces Groundbreaking Mass Spectrometer To Revolutionize Biological Discovery
Thermo Fisher Scientific Inc. (NYSE: TMO), unveiled the Thermo Scientific™ Orbitrap™ Astral™ mass spectrometer.
Product News
OncoHost To Present PROphet® Biomarker Model That Accurately Predicts Clinical Benefit to ICI-Based Treatment
OncoHost has announced that it will give a poster presentation demonstrating the accuracy of its PROphet® biomarker model at the upcoming American Society of Clinical Oncology Annual Meeting, taking place June 2-6, 2023, in Chicago, Illinois.
Product News
Xyall and Indica Labs Collaborate To Transform Precision Oncology Workflows
Xyall and Indica Labs have entered into a global strategic partnership designed to bridge the gap between histology and molecular pathology.
Product News
Agilent Announces NGS Assay for Comprehensive Genomic Profiling
Agilent Technologies Inc. has announced the launch of the Agilent SureSelect Cancer CGP Assay designed for somatic variant profiling for a broad range of solid tumor types.
Product News
Agilent and PathAI Partner To Deliver AI-Powered Assay Development Solutions
Agilent Technologies Inc. has announced a strategic partnership with PathAI to deliver biopharmaceutical organizations a solution that combines Agilent’s assay development expertise and PathAI’s algorithm development capabilities.
Product News
Certis Oncology Solutions Announces Three Abstracts Accepted for Presentation at AACR Annual Meeting
Certis Oncology Solutions has announced that three abstracts have been accepted for presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting.
Product News
Personalis Joins Top UK Cancer Research Organizations To Evaluate Earlier Cancer Recurrence Detection
Personalis, Inc., Cancer Research UK’s Cancer Research Horizons, University College London and the Francis Crick Institute have announced a collaboration to deploy a personalized liquid biopsy-based research assay, for the TRACERx study.
Product News
Aptamer Launches Optimer®-Fc as a New Reagent Solution for Immunohistochemistry
Aptamer Group plc announces that it has developed a new reagent, Optimer®-Fc, for use in automated immunohistochemistry (IHC) workflows.
Product News
Owlstone Medical Enters Partnership To Develop Probes for Early Cancer Detection
Owlstone Medical has announced that it has entered into a Research Agreement with Bicycle Therapeutics plc.
Product News
Personalis and Moderna Sign New Agreement To Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials
The platform will be used to sequence genomic information from a patient’s tumor sample to identify the unique genetic mutations that are most likely to generate a tailored antitumor response.
Advertisement